According to a pooled analysis encompassing 5,925 TAVR and 1,832 SAVR patients, a low incidence of reintervention was observed for CoreValve/Evolut R/PRO and SAVR through 5 years. Notably, reintervention occurred most often at ≤1 year for TAVR and >1 year for SAVR, and were more common following CoreValve TAVR compared with Evolut TAVR or SAVR jacc.org/doi/10.1016/j.… @JACCJournals @EdwardsLifesci @Medtronic
0
1
7
809
2
Download Image